Pfizer Inc. today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of BRAFTOVI® (encorafenib) in combination with cetuximab ...

Because H5N1 is a form of influenza A ... "Having learned from the COVID pandemic, we want to be prepared," Chopra said. "We are developing our own ... in-house test. ... If we have evidence ...

Enhancing pharmacovigilance ... form that I can fill out quickly on my phone or computer would make a big difference.” (Pharmacist: 11). “Digitalizing the reporting process would reduce the burden and ...

Spontaneous reporting continues to play an important role in pharmacovigilance and the value of astute clinical observation and well-documented reports of suspicions of a causal link cannot be ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

So when does 9-1-1 return with new episodes? We’ve got answers. 9-1-1‘s midseason finale, which aired back on November 21, 2024, was fairly tame compared to fans’ expectations. But the ...

CDC testing data for the same period reveals that 6.6 percent of COVID-19 tests came back positive, with Illinois, Indiana, ...

The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.

A study done by the University of Minnesota (U of M) found that early adult deaths are on the rise in the U.S., with COVID-19 ...

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.